Search research articles
Contact Us
Filters
Showing results (381-390 of 405) with videos related to
Page
of 41
Sort By:
BMC Cancer
|
June 7, 2022
Rationale and design of ON-TRK: a novel prospective non-interventional study in patients with TRK fusion cancer treated with larotrectinib
James C H Yang, Marcia S Brose, Gilberto Castro, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 15, 2022
Biomarker-driven therapies for metastatic uveal melanoma: A prospective precision oncology feasibility study
Serge Leyvraz, Frank Konietschke, Caroline Peuker, et al.
International Journal of Cancer
|
February 24, 2006
Docetaxel and gemcitabine combination in 133 advanced soft-tissue sarcomas: a retrospective analysis
Jacques-Olivier Bay, Isabelle Ray-Coquard, Jérôme Fayette, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 27, 2020
Support of a molecular tumour board by an evidence-based decision management system for precision oncology
Mario Lamping, Manuela Benary, Serge Leyvraz, et al.
The Oncologist
|
June 17, 2024
A diagnostic challenge of KIT p.V559D and BRAF p.G469A mutations in a paragastric mass
Stefan Habringer, Jana Ihlow, Karsten Kleo, et al.
Cancer
|
January 10, 2018
Long-term outcome of dasatinib first-line treatment in gastrointestinal stromal tumor: A multicenter, 2-stage phase 2 trial (Swiss Group for Clinical Cancer Research 56/07)
Michael Montemurro, Angela Cioffi, Julien Dômont, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 11, 2014
Adjuvant radiotherapy for extremity and trunk wall atypical lipomatous tumor/well-differentiated LPS (ALT/WD-LPS): a French Sarcoma Group (GSF-GETO) study
P A Cassier, G Kantor, S Bonvalot, et al.
Journal for Immunotherapy of Cancer
|
June 6, 2024
Long-term survival follow-up for tebentafusp in previously treated metastatic uveal melanoma
Joseph J Sacco, Richard D Carvajal, Marcus O Butler, et al.
European Journal of Endocrinology
|
March 25, 2022
Efficacy and safety of larotrectinib in patients with TRK fusion-positive thyroid carcinoma
Steven G Waguespack, Alexander Drilon, Jessica J Lin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 22, 2012
Outcome of patients with platelet-derived growth factor receptor alpha-mutated gastrointestinal stromal tumors in the tyrosine kinase inhibitor era
Philippe A Cassier, Elena Fumagalli, Piotr Rutkowski, et al.
Page
of 41
Search research articles
Search
Showing results (381-390 of 405) with videos related to
Sort By:
Page
of 41
BMC Cancer
|
June 7, 2022
Rationale and design of ON-TRK: a novel prospective non-interventional study in patients with TRK fusion cancer treated with larotrectinib
James C H Yang, Marcia S Brose, Gilberto Castro, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 15, 2022
Biomarker-driven therapies for metastatic uveal melanoma: A prospective precision oncology feasibility study
Serge Leyvraz, Frank Konietschke, Caroline Peuker, et al.
International Journal of Cancer
|
February 24, 2006
Docetaxel and gemcitabine combination in 133 advanced soft-tissue sarcomas: a retrospective analysis
Jacques-Olivier Bay, Isabelle Ray-Coquard, Jérôme Fayette, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 27, 2020
Support of a molecular tumour board by an evidence-based decision management system for precision oncology
Mario Lamping, Manuela Benary, Serge Leyvraz, et al.
The Oncologist
|
June 17, 2024
A diagnostic challenge of KIT p.V559D and BRAF p.G469A mutations in a paragastric mass
Stefan Habringer, Jana Ihlow, Karsten Kleo, et al.
Cancer
|
January 10, 2018
Long-term outcome of dasatinib first-line treatment in gastrointestinal stromal tumor: A multicenter, 2-stage phase 2 trial (Swiss Group for Clinical Cancer Research 56/07)
Michael Montemurro, Angela Cioffi, Julien Dômont, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 11, 2014
Adjuvant radiotherapy for extremity and trunk wall atypical lipomatous tumor/well-differentiated LPS (ALT/WD-LPS): a French Sarcoma Group (GSF-GETO) study
P A Cassier, G Kantor, S Bonvalot, et al.
Journal for Immunotherapy of Cancer
|
June 6, 2024
Long-term survival follow-up for tebentafusp in previously treated metastatic uveal melanoma
Joseph J Sacco, Richard D Carvajal, Marcus O Butler, et al.
European Journal of Endocrinology
|
March 25, 2022
Efficacy and safety of larotrectinib in patients with TRK fusion-positive thyroid carcinoma
Steven G Waguespack, Alexander Drilon, Jessica J Lin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 22, 2012
Outcome of patients with platelet-derived growth factor receptor alpha-mutated gastrointestinal stromal tumors in the tyrosine kinase inhibitor era
Philippe A Cassier, Elena Fumagalli, Piotr Rutkowski, et al.
Page
of 41